Cybele Microbiome develops scientific platforms that evaluate how cosmetic ingredients alter skin microbiome composition and the resulting postbiotic outputs. By integrating microbiome profiling with clinical efficacy data, the company creates formulations that aim for higher efficacy and reduced side effects, targeting skincare brands and manufacturers. Revenue is generated through licensing of its microbiome assessment technology and collaborative product development partnerships.
Funding
$500K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional skincare formulations often overlook the crucial role of the skin's microbiome, potentially disrupting its balance and leading to suboptimal outcomes. Many products fail to consider the impact of ingredients on the microbiome's composition and its subsequent effects on skin health.
Solution
Cybele Microbiome develops technologies to analyze and optimize skincare formulations by assessing the effects of ingredients on the skin's microbiome and their postbiotic outputs. Their approach focuses on understanding the complex interactions between ingredients, the microbiome, and the skin to enhance overall skin health. By identifying how ingredients affect the microbiome's composition and downstream postbiotic production, Cybele Microbiome enables the creation of skincare products with improved efficacy and reduced side effects. The company leverages clinical trials to demonstrate the real-world results of their microbiome-optimized formulations.
Target Audience
Cybele Microbiome primarily serves skincare formulators and manufacturers seeking to develop products that promote a healthy skin microbiome.
Features
- Analysis of ingredient effects on microbiome composition
- Evaluation of downstream effects on postbiotic output
- Optimization of skincare formulations for microbiome compatibility
- Clinical trials to validate efficacy and safety